Advances in Cardiology – Interventional Technologies in 2022

Abstract
Heart disease remains the number killer of men and women in the US and globally. Unexpectedly, COVID-19 has emerged as a major new cause of cardiac damage. In this Forum, you will hear from leaders in interventional cardiology who are developing technologies to overcome challenges in treating cardiovascular patients. These include imaging, drug delivery, biomarkers for COVID-19 related clot formation, and structural heart disease. Hear and meet these leaders in CV disease diagnosis and treatment.